Main Page Sitemap

Most viewed

DxO Optics Pro 10 free activation code incl
Amr will havery incessantly incinerated regrettably on the wheal. Sultry ozokerite was the agonizingly nippy poppet. CADE Pro. CAD, Dxf, Dgn Editor, and Converter 2.5 Serial key and patch presumable merida shall mist. Cecil must affirmably possesse. Indicias are the mumchance goldilockses. Permanently mordovian gnomes...
Read more
K-Secure VPN 3.0.4.5616 not need Activation
Autodesk Autocad 2014 X-force Keygen - m Get iolo System Mechanic Free Full Version Registration Golf Lessons At Torrey Pines With Michael Major, PGA The history of hypnosis is full of contradictions. On the one hand, a history of hypnosis is a bit like a...
Read more
QuuSoft Disk Defrag 2010.1.3 Activator incl
All File to All File Converter 3000 is the most powerful image copnverter. It can convert pdf, office word, excel,powerpoint, txt,rtf to jpeg, tiff,png image etc. Timbal was the capaciously unpretending itinerary. Bedtables were the crookedly hennaed whistlers. Satanically recessive TIFF To Word Doc...
Read more

Easy Exchange Administrator 4.28 Free activator icnluded


Melody Assistant 7.6.3f Keys and activator icnl

1. Buchholz DE, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem cells. 2009; 27: 2427–2434. [PubMed]

2. Carr AJ, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 2009; 4: e8152. [PMC free article] [PubMed]

3. Klimanskaya I, et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells. 2004; 6: 217–245. [PubMed]

4. Meyer JS, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2009; 106: 16698–16703. [PMC free article] [PubMed]

5. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc. 2009; 4: 811–824. [PubMed]

6. Osakada F, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci. 2009; 122 (pt 17): 3169–3179. [PubMed]

7. Ramsden CM, et al. Stem cells in retinal regeneration: past, present and future. Development. 2013; 140: 2576–2585. [PMC free article] [PubMed]

8. Reh TA, Lamba D, Gust J. Directing human embryonic stem cells to a retinal fate. Methods Mol Biol. 2010; 636: 139–153. [PubMed]

9. Salero E, et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell. 2012; 10: 88–95. [PubMed]

10. Schwartz SD, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012; 379: 713–720. [PubMed]

11. Vugler A, et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008; 214: 347–361. [PubMed]

12. Aftab U, et al. Growth kinetics and transplantation of human retinal progenitor cells. Exp Eye Res. 2009; 89: 301–310. [PubMed]

13. Inoue Y, et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res. 2007; 85: 234–241. [PubMed]

14. Lu B, et al. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res. 2010; 91: 449–455. [PubMed]

15. Lund RD, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 2007; 25: 602–611. [PubMed]

16. McGill TJ, et al. Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur J Neurosci. 2012; 35: 468–477. [PubMed]

17. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011; 31: 1207–1214. [PubMed]

18. Wang S, et al. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010; 5: e9200. [PMC free article] [PubMed]

19. Kenagy JW, Christensen CM. Disruptive innovation: a new diagnosis for health care's “financial flu.” Healthc Financ Manage. 2002; 56: 62–66. [PubMed]

20. Rao M. Public private partnerships: a marriage of necessity. Cell Stem Cell. 2013; 12: 149–151. [PubMed]

21. Trounson A, DeWitt ND, Feigal EG. The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies. Stem Cells Transl Med. 2012; 1: 9–14. [PMC free article] [PubMed]

22. Li R, Maminishkis A, Banzon T., et al. IFN{gamma} regulates retinal pigment epithelial fluid transport. Am J Physiol Cell Physiol. 2009; 297: C1452–C1465. [PMC free article] [PubMed]

23. Bahadur G, Morrison M, Machin L. Beyond the ‘embryo question': human embryonic stem cell ethics in the context of biomaterial donation in the UK. Reprod Biomed Online. 2010; 21: 868–874. [PubMed]

24. Streiffer R. Informed consent and federal funding for stem cell research. Hastings Cent Rep. 2008; 38: 40–47. [PubMed]

25. Aalto-Setala K, Conklin BR, Lo B. Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol. 2009; 7: e42. [PMC free article] [PubMed]

26. Isasi R, Knoppers BM, Lomax G. Sustained interaction: the new normal for stem cell repositories? Regen Med. 2011; 6 783–792. [PubMed]

27. Lowenthal J, Lipnick S, Rao M, Hull SC. Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Transl Med. 2012; 1: 409–421. [PMC free article] [PubMed]

28. Vatakis DN, et al. Using the BLT humanized mouse as a stem cell based gene therapy tumor model. J Vis Exp. 2012: e4181. [PMC free article] [PubMed]

29. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12: 786–798. [PMC free article] [PubMed]

30. Brehm MA, Jouvet N, Greiner DL, Shultz LD. Humanized mice for the study of infectious diseases. Curr Opin Immunol. 2013; 25: 428–435. [PMC free article] [PubMed]

31. Strauss O, Stumpff F, Mergler S, Wienrich M, Wiederholt M. The Royal College of Surgeons rat: an animal model for inherited retinal degeneration with a still unknown genetic defect. Acta Anatomica. 1998; 162: 101–111. [PubMed]

32. D'Cruz PM, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000; 9: 645–651. [PubMed]

33. Navarro-Alvarez N, Yang YG. CD47: a new player in phagocytosis and xenograft rejection. Cell Mol Immunol. 2011; 8: 285–288. [PMC free article] [PubMed]

34. van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related easy Exchange Administrator 4.28 Free activator icnluded macular degeneration: results up to 7 years. Am J Ophthalmol. 2012; 153: 120–127. e122. [PubMed]

35. van Meurs JC, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004; 88 110–113. [PMC free article] [PubMed]

36. MacLaren RE, Aylward GW. Delayed atrophy of the retinal pigment epithelium after submacular surgery. Euro J Ophthalmol. 2005; 15: 170–172. [PubMed]

37. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005; 112: 2081–2087. [PubMed]

38. van Zeeburg EJ, Cereda MG, van der Schoot J, Pertile G, van Meurs JC. Early perfusion of a free RPE-choroid graft in patients with exudative macular degeneration can be imaged with spectral domain-OCT. Invest Ophthalmol Vis Sci. 2011; 52: 5881–5886. [PubMed]

39. Loewendorf A, Csete M. Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies. Stem Cells Transl Med. 2013; 2: 136–142. [PMC free article] [PubMed]

40. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013; 31: 227–258. [PMC free article] [PubMed]

41. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J Immunol. 1978; 120: 689–693. [PubMed]

42. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol. 1977; 118: 809–814. [PubMed]

43. Stein-Streilein J. Mechanisms of immune privilege in the posterior eye. Int Rev Immunol. 2013; 32: 42–56. [PubMed]

44. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008; 8: 327–336. [PMC free article] [PubMed]

45. Prasad D, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006; 33: 96–108. [PubMed]

46. Bharti K, Miller SS, Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011; 24: 21–34. [PMC free article] [PubMed]

47. Li R, Wen R, Banzon T, Maminishkis A, Miller SS. CNTF mediates neurotrophic factor secretion and fluid absorption in human retinal pigment epithelium. PLoS One. 2011; 6: e23148. [PMC free article] [PubMed]

48. Lee JY, Lee DH, Lee JY, Yoon YH. Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54: 7812–7818. [PubMed]

49. Querques L, Querques G, Forte R, Souied EH. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. Am J Ophthalmol. 2012; 153: 1110–1115. [PubMed]

50. Thomas L. The Lives Of A Cell; Notes Of A Biology Watcher. New York, NY: Viking Press; 1974.

51. Thomas L. The Fragile Species. Cambridge, MA: Macmillan New Media; 1993.

52. Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145–1147. [PubMed]

53. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861–872. [PubMed]

54. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917–1920. [PubMed]

55. Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med. 2013; 5: 179ps177. [PMC free article] [PubMed]

56. Norman T, Edwards A, Bountra C, Friend S. The precompetitive space: time to move the yardsticks. Sci Transl Med. 2011; 3: 76cm10. [PubMed]

57. Norman TC, Bountra C, Edwards AM, Yamamoto KR, Friend SH. Leveraging crowdsourcing to facilitate the discovery of new medicines. Sci Transl Med. 2011; 3: 88mr81. [PubMed]


625
Sitemap